ATCC provides trusted, cutting-edge models that empower breakthroughs in diagnostics development, drug discovery, and translational research.
Through targeted accessions and strategic partnerships, we deliver clinically relevant microorganisms and patient-derived cell lines that advance research in critical public health initiatives such as antimicrobial resistance, infectious disease, and cancer research. We also conduct our own internal research using the latest techniques and technologies to drive the development of innovative products with enhanced specificity and functionality. Explore our newest products below to discover how we can move your research forward.
